Imperial College London

ProfessorJorgeFerrer

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Medicine and Genetics
 
 
 
//

Contact

 

+44 (0)20 7594 0968j.ferrer

 
 
//

Location

 

535ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Wessel:2020:10.1101/2020.11.13.20221812,
author = {Wessel, J and Majarian, TD and Highland, HM and Raghavan, S and Szeto, MD and Hasbani, NR and de, Vries PS and Brody, JA and Sarnowski, C and DiCorpo, D and Yin, X and Hidalgo, B and Guo, X and Perry, J and OConnell, JR and Lent, S and Montasser, ME and Cade, BE and Jain, D and Wang, H and Wu, P and Bonàs-Guarch, S and DOliveira, Albanus R and Leong, A and Miguel-Escalada, I and Varshney, A and Kinney, GL and Yanek, LR and Lange, L and Almeida, M and Peralta, JM and Aslibekyan, S and Baldridge, AS and Bertoni, AG and Bielak, LF and Bowden, DW and Chen, C-S and Chen, Y-DI and Choi, SH and Choi, WJ and Darbar, D and Floyd, JS and Freedman, BI and Goodarzi, MO and Irvin, R and Kalyani, RR and Kelly, T and Lee, S and Liu, C-T and Loesch, D and Manson, JE and Nassir, R and Palmer, ND and Pankow, JS and Rasmussen-Torvik, LJ and Reiner, AP and Selvin, E and Shadyab, AH and Smith, JA and Weeks, DE and Weng, L-C and Xu, H and Yao, J and Yoneda, Z and Zhao, W and Ferrer, J and Mahajan, A and McC},
doi = {10.1101/2020.11.13.20221812},
title = {Rare Non-coding Variation Identified by Large Scale Whole Genome Sequencing Reveals Unexplained Heritability of Type 2 Diabetes},
url = {http://dx.doi.org/10.1101/2020.11.13.20221812},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - <jats:p>Type 2 diabetes is increasing in all ancestry groups<jats:sup>1</jats:sup>. Part of its genetic basis may reside among the rare (minor allele frequency <0.1%) variants that make up the vast majority of human genetic variation<jats:sup>2</jats:sup>. We analyzed high-coverage (mean depth 38.2x) whole genome sequencing from 9,639 individuals with T2D and 34,994 controls in the NHLBI’s Trans-Omics for Precision Medicine (TOPMed) program<jats:sup>2</jats:sup> to show that rare, non-coding variants that are poorly captured by genotyping arrays or imputation panels contribute h<jats:sup>2</jats:sup>=53% (P=4.2×10<jats:sup>−5</jats:sup>) to the genetic component of risk in the largest (European) ancestry subset. We coupled sequence variation with islet epigenomic signatures<jats:sup>3</jats:sup> to annotate and group rare variants with respect to gene expression<jats:sup>4</jats:sup>, chromatin state<jats:sup>5</jats:sup> and three-dimensional chromatin architecture<jats:sup>6</jats:sup>, and show that pancreatic islet regulatory elements contribute to T2D genetic risk (h<jats:sup>2</jats:sup>=8%, P=2.4×10<jats:sup>−3</jats:sup>). We used islet annotation to create a non-coding framework for rare variant aggregation testing. This approach identified five loci containing rare alleles in islet regulatory elements that suggest novel biological mechanisms readily linked to hypotheses about variant-to-function. Large scale whole genome sequence analysis reveals the substantial contribution of rare, non-coding variation to the genetic architecture of T2D and highlights the value of tissue-specific regulatory annotation for variant-to-function discovery.</jats:p>
AU - Wessel,J
AU - Majarian,TD
AU - Highland,HM
AU - Raghavan,S
AU - Szeto,MD
AU - Hasbani,NR
AU - de,Vries PS
AU - Brody,JA
AU - Sarnowski,C
AU - DiCorpo,D
AU - Yin,X
AU - Hidalgo,B
AU - Guo,X
AU - Perry,J
AU - OConnell,JR
AU - Lent,S
AU - Montasser,ME
AU - Cade,BE
AU - Jain,D
AU - Wang,H
AU - Wu,P
AU - Bonàs-Guarch,S
AU - DOliveira,Albanus R
AU - Leong,A
AU - Miguel-Escalada,I
AU - Varshney,A
AU - Kinney,GL
AU - Yanek,LR
AU - Lange,L
AU - Almeida,M
AU - Peralta,JM
AU - Aslibekyan,S
AU - Baldridge,AS
AU - Bertoni,AG
AU - Bielak,LF
AU - Bowden,DW
AU - Chen,C-S
AU - Chen,Y-DI
AU - Choi,SH
AU - Choi,WJ
AU - Darbar,D
AU - Floyd,JS
AU - Freedman,BI
AU - Goodarzi,MO
AU - Irvin,R
AU - Kalyani,RR
AU - Kelly,T
AU - Lee,S
AU - Liu,C-T
AU - Loesch,D
AU - Manson,JE
AU - Nassir,R
AU - Palmer,ND
AU - Pankow,JS
AU - Rasmussen-Torvik,LJ
AU - Reiner,AP
AU - Selvin,E
AU - Shadyab,AH
AU - Smith,JA
AU - Weeks,DE
AU - Weng,L-C
AU - Xu,H
AU - Yao,J
AU - Yoneda,Z
AU - Zhao,W
AU - Ferrer,J
AU - Mahajan,A
AU - McCarthy,MI
AU - Parker,S
AU - Alonso,A
AU - Arnett,DK
AU - Blangero,J
AU - Boerwinkle,E
AU - Cho,MH
AU - Correa,A
AU - Cupples,LA
AU - Curran,JE
AU - Duggirala,R
AU - Ellinor,PT
AU - He,J
AU - Heckbert,SR
AU - Kardia,SLR
AU - Kim,RW
AU - Kooperberg,C
AU - Liu,S
AU - Lubitz,SA
AU - Mathias,RA
AU - McGarvey,S
AU - Mitchell,BD
AU - Morrison,AC
AU - Peyser,PA
AU - Psaty,BM
AU - Redline,S
AU - Roden,D
AU - Shoemaker,MB
AU - Smith,NL
AU - Taylor,KD
AU - Vasan,RS
AU - Viaud-Martinez,KA
AU - Florez,JC
AU - Wilson,JG
AU - Sladek,R
AU - Dupuis,J
AU - Rich,SS
AU - Rotter,JI
AU - Meigs,JB
AU - Manning,AK
DO - 10.1101/2020.11.13.20221812
PY - 2020///
TI - Rare Non-coding Variation Identified by Large Scale Whole Genome Sequencing Reveals Unexplained Heritability of Type 2 Diabetes
UR - http://dx.doi.org/10.1101/2020.11.13.20221812
ER -